Glen Harbor Capital Management LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 178 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
Glen Harbor Capital Management LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$500,000
+74.8%
17,752
+64.2%
0.01%
+66.7%
Q2 2019$286,000
+717.1%
10,808
+467.6%
0.01%
+500.0%
Q1 2019$35,000
-87.2%
1,904
-91.3%
0.00%
-85.7%
Q4 2018$273,000
-48.8%
21,980
-20.9%
0.01%
-36.4%
Q3 2018$533,000
+257.7%
27,804
+154.0%
0.01%
+266.7%
Q2 2018$149,000
+84.0%
10,948
-2.7%
0.00%
+50.0%
Q1 2018$81,00011,2560.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,303$54,386,00028.54%
JOHNSON & JOHNSON 3,260,869$216,196,00024.61%
ACT CAPITAL MANAGEMENT, LLC 210,500$13,956,00010.09%
Aquilo Capital Management, LLC 700,426$46,438,0005.27%
WEALTH EFFECTS LLC 145,960$9,677,0004.02%
Evolutionary Tree Capital Management, LLC 115,580$7,663,0003.68%
ACUTA CAPITAL PARTNERS, LLC 105,500$6,995,0002.94%
Privium Fund Management B.V. 204,393$13,766,0002.73%
L1 Capital Pty Ltd 292,735$19,408,0002.24%
Avidity Partners Management LP 875,000$58,013,0001.23%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders